Source:http://linkedlifedata.com/resource/pubmed/id/11704162
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
5 Pt 1
|
| pubmed:dateCreated |
2001-11-12
|
| pubmed:abstractText |
To evaluate the efficacy and safety of venlafaxine, a new-generation antidepressant that selectively inhibits serotonin and norepinephrine reuptake, in the treatment of premenstrual dysphoric disorder (PMDD).
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Nov
|
| pubmed:issn |
0029-7844
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
98
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
737-44
|
| pubmed:dateRevised |
2009-10-26
|
| pubmed:meshHeading |
pubmed-meshheading:11704162-Adult,
pubmed-meshheading:11704162-Cyclohexanols,
pubmed-meshheading:11704162-Double-Blind Method,
pubmed-meshheading:11704162-Female,
pubmed-meshheading:11704162-Humans,
pubmed-meshheading:11704162-Premenstrual Syndrome,
pubmed-meshheading:11704162-Psychiatric Status Rating Scales,
pubmed-meshheading:11704162-Serotonin Uptake Inhibitors
|
| pubmed:year |
2001
|
| pubmed:articleTitle |
Venlafaxine in the treatment of premenstrual dysphoric disorder.
|
| pubmed:affiliation |
Department of Obstetrics/Gynecology, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA. freemane@mail.med.upenn.edu
|
| pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|